Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Advances in Immunology
|
July 13, 2019
The airway epithelium in asthma
Luke R Bonser, David J Erle
Journal of Clinical Medicine
|
November 30, 2017
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B
Luke R Bonser, David J Erle
American Journal of Respiratory and Critical Care Medicine
|
October 31, 2018
Putting Mucins on the Map
Luke R Bonser, David J Erle
The Journal of Clinical Investigation
|
May 17, 2016
Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma
Luke R Bonser, Lorna Zlock, Walter Finkbeiner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 10, 2015
The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway
Luke R Bonser, Bradley W Schroeder, Lisa A Ostrin, et al.
Chest
|
July 19, 2017
MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma
Kathryn G Welsh, Karine Rousseau, Gemma Fisher, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 19, 2014
Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma
Dan Cheng, Zheng Xue, Lingling Yi, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 10, 2019
Efficient RNP-directed Human Gene Targeting Reveals SPDEF Is Required for IL-13-induced Mucostasis
Kyung Duk Koh, Sana Siddiqui, Dan Cheng, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2021
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
Luke R Bonser, Walter L Eckalbar, Lauren Rodriguez, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 4, 2022
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
Luke R Bonser, Walter L Eckalbar, Lauren Rodriguez, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Advances in Immunology
|
July 13, 2019
The airway epithelium in asthma
Luke R Bonser, David J Erle
Journal of Clinical Medicine
|
November 30, 2017
Airway Mucus and Asthma: The Role of MUC5AC and MUC5B
Luke R Bonser, David J Erle
American Journal of Respiratory and Critical Care Medicine
|
October 31, 2018
Putting Mucins on the Map
Luke R Bonser, David J Erle
The Journal of Clinical Investigation
|
May 17, 2016
Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma
Luke R Bonser, Lorna Zlock, Walter Finkbeiner, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 10, 2015
The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway
Luke R Bonser, Bradley W Schroeder, Lisa A Ostrin, et al.
Chest
|
July 19, 2017
MUC5AC and a Glycosylated Variant of MUC5B Alter Mucin Composition in Children With Acute Asthma
Kathryn G Welsh, Karine Rousseau, Gemma Fisher, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 19, 2014
Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma
Dan Cheng, Zheng Xue, Lingling Yi, et al.
American Journal of Respiratory Cell and Molecular Biology
|
October 10, 2019
Efficient RNP-directed Human Gene Targeting Reveals SPDEF Is Required for IL-13-induced Mucostasis
Kyung Duk Koh, Sana Siddiqui, Dan Cheng, et al.
Biorxiv : the Preprint Server for Biology
|
March 3, 2021
The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium
Luke R Bonser, Walter L Eckalbar, Lauren Rodriguez, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 4, 2022
The Type 2 Asthma Mediator IL-13 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection of Bronchial Epithelium
Luke R Bonser, Walter L Eckalbar, Lauren Rodriguez, et al.
Page
of 2